2017年4月23日日曜日

Pitavastatin Pleiotropic Study



https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387666/



Conclusions

Pitavastatin not only improved atherosis measured by IMT and the sclerosis measured by cIBS values, but also attenuated inflammation of plaques at the same site as measured by max SUV. The present study indicated that pitavastatin had a stronger effect on regression and stabilization of plaques in the thoracic aorta compared with a mild hydrophilic statin.

Acknowledgements

This study was funded by a grant from Japan vascular disease research foundation, Kyoto, Japan.

Simple Radical Metabolic Pathways for Anti-TB Drug & Others

 

Radical Metabolic Pathways

For Isoniazid, Delamanid and Epalrestat.



This Paper deals with the new radical metabolic patway
for two ant-TB drugs (Isoniazid and Delamanid) and one
ARI (aldose reductase inhibitor).






http://www.pnas.org/content/100/24/13881.full







Pitavastatin Works As RhoA

 

Inverse Agonist But Not GPCR120 Ligand.